Sanket Acharya

Sanket Acharya, PhD, currently serves as Senior Director of Corporate Development at GenScript, where responsibilities include strategic analysis of new markets and managing the entire deal process. Prior to this role, Sanket was Director of Open Innovation for Cell and Gene Therapy at Cytiva, focusing on next-generation modality strategy and technology licensing. With extensive consulting experience at L.E.K. Consulting, Sanket advised biopharma clients across various therapeutic areas. Academic achievements include a PhD in Immunology from Harvard University, complemented by a Master of Business and Science from Keck Graduate Institute and a Bachelor of Arts in Biochemistry and Molecular Biology from Hampshire College.